And critically for obesity research, it acts centrally: amylin binds to receptors in the area postrema and the brainstem, where it generates satiety signals that communicate to the brain that the body has had enough to eat
Patients taking medications that promote weight gain (such as insulin, sulfonylureas, or certain antipsychotics) may experience attenuated weight loss, though glucose control typically improves regardless
This article examines the mechanisms of semaglutide's appetite effects, common causes of persistent hunger, and evidence-based strategies to address this challenge during therapy
It is important to note that ICD-10 is used primarily in secondary care for hospital activity reporting and commissioning
But beyond the headlines, what does this boom tell us about where pharma marketing is heading in 2026
Some studies suggest GLP-1s may even have neutral or protective effects on bone health